Our results showed that OS of HER2-nonamplified BC with low Ki-67 index was statistically better than those HER2-nonamplified BC presented a high Ki-67 index (92% vs. 90%, p=0.021, Figure 2(a)). This evidence concerns the gene ERBB2 and breast cancer.